436 related articles for article (PubMed ID: 18835921)
1. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
[TBL] [Abstract][Full Text] [Related]
2. Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart.
Gross GJ; Gauthier KM; Moore J; Falck JR; Hammock BD; Campbell WB; Nithipatikom K
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2838-44. PubMed ID: 18441205
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury.
Chaudhary KR; Abukhashim M; Hwang SH; Hammock BD; Seubert JM
J Cardiovasc Pharmacol; 2010 Jan; 55(1):67-73. PubMed ID: 19834332
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling.
Merkel MJ; Liu L; Cao Z; Packwood W; Young J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H679-87. PubMed ID: 20008276
[TBL] [Abstract][Full Text] [Related]
5. Soluble epoxide hydrolase: a novel therapeutic target in stroke.
Zhang W; Koerner IP; Noppens R; Grafe M; Tsai HJ; Morisseau C; Luria A; Hammock BD; Falck JR; Alkayed NJ
J Cereb Blood Flow Metab; 2007 Dec; 27(12):1931-40. PubMed ID: 17440491
[TBL] [Abstract][Full Text] [Related]
6. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia.
Zhang W; Otsuka T; Sugo N; Ardeshiri A; Alhadid YK; Iliff JJ; DeBarber AE; Koop DR; Alkayed NJ
Stroke; 2008 Jul; 39(7):2073-8. PubMed ID: 18369166
[TBL] [Abstract][Full Text] [Related]
7. Soluble epoxide hydrolase: a new target for cardioprotection.
Gross GJ; Nithipatikom K
Curr Opin Investig Drugs; 2009 Mar; 10(3):253-8. PubMed ID: 19333883
[TBL] [Abstract][Full Text] [Related]
8. Linoleic Acid Metabolite DiHOME Decreases Post-ischemic Cardiac Recovery in Murine Hearts.
Bannehr M; Löhr L; Gelep J; Haverkamp W; Schunck WH; Gollasch M; Wutzler A
Cardiovasc Toxicol; 2019 Aug; 19(4):365-371. PubMed ID: 30725262
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice.
Chaudhary KR; Zordoky BN; Edin ML; Alsaleh N; El-Kadi AO; Zeldin DC; Seubert JM
Prostaglandins Other Lipid Mediat; 2013; 104-105():8-17. PubMed ID: 22922020
[TBL] [Abstract][Full Text] [Related]
10. Novel soluble epoxide hydrolase inhibitor protects mitochondrial function following stress.
Batchu SN; Lee SB; Samokhvalov V; Chaudhary KR; El-Sikhry H; Weldon SM; Seubert JM
Can J Physiol Pharmacol; 2012 Jun; 90(6):811-23. PubMed ID: 22624559
[TBL] [Abstract][Full Text] [Related]
11. Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1α via downregulation of prolyl hydroxylase 3.
Neckář J; Hsu A; Hye Khan MA; Gross GJ; Nithipatikom K; Cyprová M; Benák D; Hlaváčková M; Sotáková-Kašparová D; Falck JR; Sedmera D; Kolář F; Imig JD
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1148-H1158. PubMed ID: 30074840
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury.
Batchu SN; Lee SB; Qadhi RS; Chaudhary KR; El-Sikhry H; Kodela R; Falck JR; Seubert JM
Br J Pharmacol; 2011 Feb; 162(4):897-907. PubMed ID: 21039415
[TBL] [Abstract][Full Text] [Related]
13. Genetic deletion of soluble epoxide hydrolase provides cardioprotective responses following myocardial infarction in aged mice.
Jamieson KL; Samokhvalov V; Akhnokh MK; Lee K; Cho WJ; Takawale A; Wang X; Kassiri Z; Seubert JM
Prostaglandins Other Lipid Mediat; 2017 Sep; 132():47-58. PubMed ID: 28104457
[TBL] [Abstract][Full Text] [Related]
14. Soluble Epoxide Hydrolase Inhibition Attenuates Excitotoxicity Involving 14,15-Epoxyeicosatrienoic Acid-Mediated Astrocytic Survival and Plasticity to Preserve Glutamate Homeostasis.
Kuo YM; Hsu PC; Hung CC; Hu YY; Huang YJ; Gan YL; Lin CH; Shie FS; Chang WK; Kao LS; Tsou MY; Lee YH
Mol Neurobiol; 2019 Dec; 56(12):8451-8474. PubMed ID: 31257558
[TBL] [Abstract][Full Text] [Related]
15. Roles of endothelial nitric oxide synthase (eNOS) and mitochondrial permeability transition pore (MPTP) in epoxyeicosatrienoic acid (EET)-induced cardioprotection against infarction in intact rat hearts.
Gross GJ; Hsu A; Pfeiffer AW; Nithipatikom K
J Mol Cell Cardiol; 2013 Jun; 59():20-9. PubMed ID: 23419451
[TBL] [Abstract][Full Text] [Related]
16. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.
Diani-Moore S; Ma Y; Gross SS; Rifkind AB
Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719
[TBL] [Abstract][Full Text] [Related]
17. Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice.
Revermann M; Schloss M; Barbosa-Sicard E; Mieth A; Liebner S; Morisseau C; Geisslinger G; Schermuly RT; Fleming I; Hammock BD; Brandes RP
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):909-14. PubMed ID: 20224052
[TBL] [Abstract][Full Text] [Related]
18. Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ.
Nayeem MA; Pradhan I; Mustafa SJ; Morisseau C; Falck JR; Zeldin DC
Am J Physiol Regul Integr Comp Physiol; 2013 Jan; 304(1):R23-32. PubMed ID: 23152114
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.
Islam O; Patil P; Goswami SK; Razdan R; Inamdar MN; Rizwan M; Mathew J; Inceoglu B; Stephen Lee KS; Hwang SH; Hammock BD
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28296232
[TBL] [Abstract][Full Text] [Related]
20. Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates MPTP-Induced Parkinsonism.
Qin X; Wu Q; Lin L; Sun A; Liu S; Li X; Cao X; Gao T; Luo P; Zhu X; Wang X
Mol Neurobiol; 2015 Aug; 52(1):187-95. PubMed ID: 25128026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]